DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Mueller S, Luderer M, Zhang D, Meulien D, Brach BS, Schou MB.
Open-label study with Nalmefene as needed use in alcohol-dependent patients with evidence of elevated liver stiffness and/or hepatic steatosis.
Alcohol Alcohol 2020;
55 (01) 63-70
Access:
We do not assume any responsibility for the contents of the web pages of other providers.